-
- Olav Dahl.
- Seksjon for onkologi, Institutt for indremedisin, Universitetet i Bergen, 5021 Bergen. olav.dahl@helse-bergen.no.
- Tidsskr. Nor. Laegeforen. 2007 Nov 29; 127 (23): 3094-6.
BackgroundRadical resection is the main treatment for adenocarcinoma of the colon. Adjuvant chemotherapy may reduce the recurrence rate of the disease. It is therefore important that those who may benefit from such therapy are offered the optimal regimens in due time. The background for adjuvant chemotherapy of colon cancer is presented.Material And MethodsThe manuscript is based on a survey of randomized clinical trials (from 1990 to 2007) retrieved from PubMed, and on own clinical experience.Results And InterpretationCure rates after curative resections of colon cancer (stage III) are improved by about 12% if patients are treated with adjuvant chemotherapy with oxaliplatin combined with 5-fluoruracil and folinat (or capecitabine) for 6 months. Certain subgroups of stage II (Dukes' stage B) are also likely to benefit from adjuvant chemotherapy.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..